Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation

Research output: Contribution to journalReviewResearchpeer-review

Standard

Pharmacological exploration of the resting membrane potential reserve : Impact on atrial fibrillation. / van der Heyden, Marcel A G; Jespersen, Thomas.

In: European Journal of Pharmacology, Vol. 771, 15.01.2016, p. 56-64.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

van der Heyden, MAG & Jespersen, T 2016, 'Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation', European Journal of Pharmacology, vol. 771, pp. 56-64. https://doi.org/10.1016/j.ejphar.2015.11.026

APA

van der Heyden, M. A. G., & Jespersen, T. (2016). Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation. European Journal of Pharmacology, 771, 56-64. https://doi.org/10.1016/j.ejphar.2015.11.026

Vancouver

van der Heyden MAG, Jespersen T. Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation. European Journal of Pharmacology. 2016 Jan 15;771:56-64. https://doi.org/10.1016/j.ejphar.2015.11.026

Author

van der Heyden, Marcel A G ; Jespersen, Thomas. / Pharmacological exploration of the resting membrane potential reserve : Impact on atrial fibrillation. In: European Journal of Pharmacology. 2016 ; Vol. 771. pp. 56-64.

Bibtex

@article{e5b401f5e2384f3c9b1fb82bdbc6cccd,
title = "Pharmacological exploration of the resting membrane potential reserve: Impact on atrial fibrillation",
abstract = "The cardiac action potential arises and spreads throughout the myocardium as a consequence of highly organized spatial and temporal expression of ion channels conducting Na(+), Ca(2+) or K(+) currents. The cardiac Na(+) current is responsible for the initiation and progression of the action potential. Altered Na(+) current has been found implicated in a number of different arrhythmias, including atrial fibrillation. In the atrium, the resting membrane potential is more depolarized than in the ventricles, and as cardiac Na(+) channels undergo voltage-dependent inactivation close to this potential, minor changes in the membrane potential have a relatively large impact on the atrial Na(+) current. The atrial resting membrane potential is established following ionic currents through the inwardly rectifying K(+) currents IK1, IK,ACh and IK,Ca and to a lesser extent by other ion channels as well as by exchangers and pumps. This review will focus on the relative and regulated contribution of IK1, IK,ACh and IK,Ca, and on pharmacological modification of the channels underlying these currents in respect to the resting membrane potential, Na(+) channel availability and atrial electrophysiology in health and disease.",
author = "{van der Heyden}, {Marcel A G} and Thomas Jespersen",
note = "Copyright {\textcopyright} 2015 Elsevier B.V. All rights reserved.",
year = "2016",
month = jan,
day = "15",
doi = "10.1016/j.ejphar.2015.11.026",
language = "English",
volume = "771",
pages = "56--64",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Pharmacological exploration of the resting membrane potential reserve

T2 - Impact on atrial fibrillation

AU - van der Heyden, Marcel A G

AU - Jespersen, Thomas

N1 - Copyright © 2015 Elsevier B.V. All rights reserved.

PY - 2016/1/15

Y1 - 2016/1/15

N2 - The cardiac action potential arises and spreads throughout the myocardium as a consequence of highly organized spatial and temporal expression of ion channels conducting Na(+), Ca(2+) or K(+) currents. The cardiac Na(+) current is responsible for the initiation and progression of the action potential. Altered Na(+) current has been found implicated in a number of different arrhythmias, including atrial fibrillation. In the atrium, the resting membrane potential is more depolarized than in the ventricles, and as cardiac Na(+) channels undergo voltage-dependent inactivation close to this potential, minor changes in the membrane potential have a relatively large impact on the atrial Na(+) current. The atrial resting membrane potential is established following ionic currents through the inwardly rectifying K(+) currents IK1, IK,ACh and IK,Ca and to a lesser extent by other ion channels as well as by exchangers and pumps. This review will focus on the relative and regulated contribution of IK1, IK,ACh and IK,Ca, and on pharmacological modification of the channels underlying these currents in respect to the resting membrane potential, Na(+) channel availability and atrial electrophysiology in health and disease.

AB - The cardiac action potential arises and spreads throughout the myocardium as a consequence of highly organized spatial and temporal expression of ion channels conducting Na(+), Ca(2+) or K(+) currents. The cardiac Na(+) current is responsible for the initiation and progression of the action potential. Altered Na(+) current has been found implicated in a number of different arrhythmias, including atrial fibrillation. In the atrium, the resting membrane potential is more depolarized than in the ventricles, and as cardiac Na(+) channels undergo voltage-dependent inactivation close to this potential, minor changes in the membrane potential have a relatively large impact on the atrial Na(+) current. The atrial resting membrane potential is established following ionic currents through the inwardly rectifying K(+) currents IK1, IK,ACh and IK,Ca and to a lesser extent by other ion channels as well as by exchangers and pumps. This review will focus on the relative and regulated contribution of IK1, IK,ACh and IK,Ca, and on pharmacological modification of the channels underlying these currents in respect to the resting membrane potential, Na(+) channel availability and atrial electrophysiology in health and disease.

U2 - 10.1016/j.ejphar.2015.11.026

DO - 10.1016/j.ejphar.2015.11.026

M3 - Review

C2 - 26601803

VL - 771

SP - 56

EP - 64

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

ER -

ID: 167806188